Navigation Links
Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
Date:6/21/2010

article formulation for intensive physical characterization, in-vitro studies, and in-vivo pharmacology and toxicology protocols to support an eventual investigational new drug (IND) filing with the U.S. Food and Drug Administration.

About Cephalon, Inc.

Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries. More information on Cephalon and its products is available at http://www.cephalon.com/.  

About Celator Pharmaceuticals, Inc.

Celator Pharmaceuticals, Inc., with locations in Princeton, NJ, and Vancouver, BC, is a privately held pharmaceutical company developing new and more effective therapies to treat cancer. CombiPlex®, the company's proprietary drug ratio technology platform, represents a novel approach that identifies molar ratios of drugs that will deliver a synergistic benefit, and locks the desired ratio in a nano-scale drug delivery vehicle that maintains the ratio in patients with the goal of impro
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
2. Isis Pharmaceuticals to Present at The Wells Fargo 2010 Healthcare Conference
3. Obamas Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets (Pharmaceuticals, Medical Devices and Health Insurance)
4. Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
5. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
6. Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market
7. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
8. Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference
9. Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
10. Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd.
11. Jazz Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: The Market for Medical Devices ... The European, Middle Eastern and African markets represent ... part of its coverage, this study: The Market ... EMEA medical device markets and estimates markets for ...
(Date:8/20/2014)... Aug 20, 2014 Reportlinker.com announces that ... its catalogue: Global Patient Scales Industry ... This report analyzes the worldwide markets for Patient ... Segments: Floor Scales, Infant & Baby Scales, Chair ... separate comprehensive analytics for the US, Canada, Japan, ...
(Date:8/20/2014)... MUMBAI , August 20, 2014 ... owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), ... studies of a novel clinical development candidate, GBR ... discovered and developed by the Glenmark Biologics Research ... . GBR 1302 is based on Glenmark,s ...
Breaking Medicine Technology:The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3
... Inc. (Nasdaq: BNVI ), a pharmaceutical company focused ... health and cancer, today announced that it had received the ... Guidance meeting that took place on November 8, 2010. In ... clinical development plan. "We had a very ...
... U.S.A. Inc., (TRL) announced today that it has entered into ... development of novel protein therapies for autoimmune diseases based on ... Anaphore will generate novel trivalent proteins called Atrimers ... inhibit targets of interest . The partnership will focus ...
Cached Medicine Technology:Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 2Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 3Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 4Tanabe Research Labs Enters R&D Partnership with Anaphore to Develop Novel Protein Pharmaceuticals for Autoimmune Disorders 2Tanabe Research Labs Enters R&D Partnership with Anaphore to Develop Novel Protein Pharmaceuticals for Autoimmune Disorders 3
(Date:8/20/2014)... (HealthDay News) -- A group representing U.S. obstetricians is ... shot. According to the American College of Obstetricians ... have upheld the safety and effectiveness of flu vaccination ... and can be particularly dangerous to pregnant women, as ... Dr. Laura Riley, chair of the college,s Immunization Expert ...
(Date:8/20/2014)... Bottom Line: A study in Australia examined patient ... rates (a marker of tumor cell growth) in ... aggressive cancer in patients. , ... in Victoria, Australia, and colleagues. , Background: ... of cell division) has been connected with prognosis ...
(Date:8/20/2014)... Aug. 20, 2014 -- An imaging study of ... found deficits in specific regions of brain white ... in CCS users. , Researchers used diffusuion ... with fractional anisotropy, to investigate the white matter ... in multiple regions of the brain, including the ...
(Date:8/20/2014)... hearts transplanted into baboons survived for more than a ... researchers report. The work is part of efforts ... transplant waiting lists. In this study, scientists transplanted ... genetic engineering and new methods of suppressing the baboons, ... survive for more than a year. The genetic ...
(Date:8/20/2014)... Dennis Thompson HealthDay Reporter ... may help older women avoid a condition that causes a ... postmenopausal women had a 10 percent lower risk of developing ... report in the Aug. 20 issue of the Journal ... this protection against the heart rhythm disorder even if they ...
Breaking Medicine News(10 mins):Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 2Health News:Exercise May Guard Against Irregular Heartbeat in Older Women 3
... a study done to evaluate the effect of diseases on ... with HIV // were less likely to get the kind ... a quarter of HIV-positive parents report avoided certain types of ... transmit the disease to their children or pick up infections ...
... People with gum disease are more likely to suffer from ... to heart attack // or stroke shows latest research . ... in the mouths of 657 people who had no history ... carotid artery, used to identify atherosclerosis, was also measured. People ...
... recent study researchers say , cancer patients have a ... clots in the legs or lungs. ,Researchers studied ... blood clot in their legs or lungs. They evaluated ... carrier status of gene mutations. Patients underwent anticoagulant (anti-clotting) ...
... at the fiber intake among kids shows , most small children ... their diets thereby putting them at higher risk for health problems ... a survey, conducted between 1994 and 1996 and in 1998, on ... of 2 and 5. Results showed most kids got what fiber ...
... can have a reduced risk of brain damage and cerebral ... after birth according to a recent study. ,Babies ... during delivery showed signs of being at a high risk ... happen immediately when babies are oxygen-deprived instead, researchers say a ...
... researchers studied comparative energetics of both lean and obese ... Results showed that NEAT -- non-exercise activity thermogenesis , ... Researchers say calories people burn during everyday activities are ... sit, on average, about 150 minutes more each day ...
Cached Medicine News:
... Lipoprint System is a high resolution diagnostic test ... by other methods. The test procedure is simple ... hours. Any abnormal value is clearly flagged. A ... atherogenic, small dense LDL in red and the ...
... is the only control for ... patient synovial fluid samples performed ... is also an aid for ... indicate a pathological condition present ...
... Suitable for use with Leica ... bilirubinometers (pediatric) and all automated ... including Aeroset, AU Series, Cobas, ... These controls contain purified bilirubin ...
... designed for point-of-care dipstick control. Its unique, ... problems and provides maximum portability ideal ... is the addition of creatinine and microalbumin. ... results for hCG for early pregnancy detection ...
Medicine Products: